Direct capture of neutralized RBD enables rapid point-of-care assessment of SARS-CoV-2 neutralizing antibody titer

Neutralizing antibody (NAb) titer is a key biomarker of protection against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, but point-of-care methods for assessing NAb titer are not widely available. Here, we present a lateral flow assay that captures SARS-CoV-2 receptor-bindi...

Descripción completa

Detalles Bibliográficos
Autores principales: Connelly, Guinevere G., Kirkland, Orville O., Bohannon, Seven, Lim, Daniel C., Wilson, Robert M., Richards, Edward J., Tay, Dousabel M., Jee, Hyuk, Hellinger, Riley D., Hoang, Ngoc K., Hao, Liang, Chhabra, Arnav, Martin-Alonso, Carmen, Tan, Edward K.W., Koehler, Angela N., Yaffe, Michael B., London, Wendy B., Lee, Pui Y., Krammer, Florian, Bohannon, Robert C., Bhatia, Sangeeta N., Sikes, Hadley D., Li, Hojun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9350670/
https://www.ncbi.nlm.nih.gov/pubmed/35942328
http://dx.doi.org/10.1016/j.crmeth.2022.100273

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9350670/
https://www.ncbi.nlm.nih.gov/pubmed/35942328
http://dx.doi.org/10.1016/j.crmeth.2022.100273

Ejemplares similares